SPRY compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SPRYARS Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SPRYARS Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SPRY 18

—ALKunlistedsupplier

—ALK U.Sunlistedsupplier

—Recordati Irelandunlistedsupplier

—Aegis Therapeuticsunlistedsupplier

14 more · SPRY chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

SPRYARS Pharmaceuticals, Inc.

3.05▼−0.16%

Mkt cap$303.3MRevenue$34MQ2 FY26Revenue$84MFY25

LLYELI Lilly & Co

1,417.69▲+0.59%

Regular sessionNov 4 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 4 '26

SPRYARS Pharmaceuticals, Inc.

LLYELI Lilly & Co

3.05▼−0.16%

Price

1,417.69▲+0.59%

$303.3M

Mkt cap

$1.3T

Q2 FY26$34M

Revenue

$24.4BQ3 FY26

FY25$84M

Revenue

$65.2BFY25

SPRY3.05▼−0.16%vsLLY1,417.69▲+0.59%Regular sessionNov 4 '26